Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Rena Buckstein, Jeannie Callum, Anca Prica, David Bowen, Richard A. Wells, Brian Leber, Nancy Heddle, Lisa Chodirker, Matthew Cheung, Lee Mozessohn, Karen Yee, Jennifer Gallagher, Anne Parmentier, Erin Jamula, Liying Zhang, Alex Mamedov, Simon J. Stanworth, Yulia Lin
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867004679105282048
author Rena Buckstein
Jeannie Callum
Anca Prica
David Bowen
Richard A. Wells
Brian Leber
Nancy Heddle
Lisa Chodirker
Matthew Cheung
Lee Mozessohn
Karen Yee
Jennifer Gallagher
Anne Parmentier
Erin Jamula
Liying Zhang
Alex Mamedov
Simon J. Stanworth
Yulia Lin
author_facet Rena Buckstein
Jeannie Callum
Anca Prica
David Bowen
Richard A. Wells
Brian Leber
Nancy Heddle
Lisa Chodirker
Matthew Cheung
Lee Mozessohn
Karen Yee
Jennifer Gallagher
Anne Parmentier
Erin Jamula
Liying Zhang
Alex Mamedov
Simon J. Stanworth
Yulia Lin
Rena Buckstein
Jeannie Callum
Anca Prica
David Bowen
Richard A. Wells
Brian Leber
Nancy Heddle
Lisa Chodirker
Matthew Cheung
Lee Mozessohn
Karen Yee
Jennifer Gallagher
Anne Parmentier
Erin Jamula
Liying Zhang
Alex Mamedov
Simon J. Stanworth
Yulia Lin
collection Wiley Open Access
contents Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE Rena Buckstein Jeannie Callum Anca Prica David Bowen Richard A. Wells Brian Leber Nancy Heddle Lisa Chodirker Matthew Cheung Lee Mozessohn Karen Yee Jennifer Gallagher Anne Parmentier Erin Jamula Liying Zhang Alex Mamedov Simon J. Stanworth Yulia Lin Transfusion AbstractBackgroundThe optimal hemoglobin (Hb) threshold for red blood cell transfusions in adult patients with myelodysplastic syndromes (MDS) has not been defined.Study Design and MethodsWe conducted a pilot randomized multi‐center study of two transfusion algorithms (liberal, to maintain Hb 110–120 g/L, transfuse 2 units if Hb < 105 g/L and 1 unit if Hb 105–110 g/L vs. restrictive, 85–105 g/L, transfuse 2 units when Hgb < 85 g/L). Primary objectives were 70% compliance in maintaining the q2 week hemoglobin within the targeted range and the achievement of a 15 g/L difference in pre‐transfusion Hb. Secondary outcomes included measures of quality of life (QOL), iron studies and safety.ResultsTwenty‐eight patients were randomized between February 2015–2020, 13 to the restrictive arm and 15 to the liberal arm in three tertiary care centers. The compliance was 66% and 45% and the mean pre‐transfusion Hb thresholds were 86 (standard deviation [SD] 8) and 98 g/L (SD 10) in the restrictive and liberal arms, (mean difference 11.8 g/L, p < .0001), respectively. Patients in the liberal arm experienced a mean of 3.4 (SD 2.6) more transfusion visits and received a mean of 5.3 (SD 5.5) more units of blood during the 12‐week study. Ferritin increased by 1043 (SD 1516) IU/L and 148 (SD 1319) IU/L in the liberal and restrictive arms, respectively. Selected QOL scores were superior pre‐transfusion and more patients achieved clinically important improvements in the liberal arm compared with the restrictive arm for selected symptoms and function domains.ConclusionThe results establish that policies for transfusion support can be delivered in practice at multiple hospitals, but further research is required to understand the full clinical effects and safety of liberal transfusion policies in MDS outpatients. 10.1111/trf.17721 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/trf.17721
format Artículo Open Access
id wiley_oa_10_1111_trf_17721
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE
Rena Buckstein
Jeannie Callum
Anca Prica
David Bowen
Richard A. Wells
Brian Leber
Nancy Heddle
Lisa Chodirker
Matthew Cheung
Lee Mozessohn
Karen Yee
Jennifer Gallagher
Anne Parmentier
Erin Jamula
Liying Zhang
Alex Mamedov
Simon J. Stanworth
Yulia Lin
Transfusion
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE Rena Buckstein Jeannie Callum Anca Prica David Bowen Richard A. Wells Brian Leber Nancy Heddle Lisa Chodirker Matthew Cheung Lee Mozessohn Karen Yee Jennifer Gallagher Anne Parmentier Erin Jamula Liying Zhang Alex Mamedov Simon J. Stanworth Yulia Lin Transfusion AbstractBackgroundThe optimal hemoglobin (Hb) threshold for red blood cell transfusions in adult patients with myelodysplastic syndromes (MDS) has not been defined.Study Design and MethodsWe conducted a pilot randomized multi‐center study of two transfusion algorithms (liberal, to maintain Hb 110–120 g/L, transfuse 2 units if Hb < 105 g/L and 1 unit if Hb 105–110 g/L vs. restrictive, 85–105 g/L, transfuse 2 units when Hgb < 85 g/L). Primary objectives were 70% compliance in maintaining the q2 week hemoglobin within the targeted range and the achievement of a 15 g/L difference in pre‐transfusion Hb. Secondary outcomes included measures of quality of life (QOL), iron studies and safety.ResultsTwenty‐eight patients were randomized between February 2015–2020, 13 to the restrictive arm and 15 to the liberal arm in three tertiary care centers. The compliance was 66% and 45% and the mean pre‐transfusion Hb thresholds were 86 (standard deviation [SD] 8) and 98 g/L (SD 10) in the restrictive and liberal arms, (mean difference 11.8 g/L, p < .0001), respectively. Patients in the liberal arm experienced a mean of 3.4 (SD 2.6) more transfusion visits and received a mean of 5.3 (SD 5.5) more units of blood during the 12‐week study. Ferritin increased by 1043 (SD 1516) IU/L and 148 (SD 1319) IU/L in the liberal and restrictive arms, respectively. Selected QOL scores were superior pre‐transfusion and more patients achieved clinically important improvements in the liberal arm compared with the restrictive arm for selected symptoms and function domains.ConclusionThe results establish that policies for transfusion support can be delivered in practice at multiple hospitals, but further research is required to understand the full clinical effects and safety of liberal transfusion policies in MDS outpatients. 10.1111/trf.17721 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE
topic Transfusion
url https://onlinelibrary.wiley.com/doi/10.1111/trf.17721